In preclinical models of Lepdb/+ pregnant mice, administration of quinoa protein hydrolysate alleviated glucose intolerance, improved liver insulin signaling, and several peptides exhibited anti-dipeptidyl peptidase-4 (DPP-IV) activity, a key enzyme involved in blood glucose control [156]. The gene discussed is DPP4; the disease is Glucose intolerance.